CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Krasfarma PAO is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Krasfarma PAO
Sverdlovskiy rayon
ul. 60 let Oktyabrya, zd. 2
Phone: +7 3912612590p:+7 3912612590 KRASNOYARSK, 660042  Russian Federation Fax: +7 3912611744f:+7 3912611744
Business Summary
Krasfarma PAO is a Russia-based pharmaceutical company specializing in the manufacture, storage, and distribution of medicinal products for the healthcare sector. The Company develops and produces a range of pharmaceutical products, including antibiotics, infusion solutions, injectable medicines, and other hospital-focused therapies. Its activities include pharmaceutical research and development, manufacturing operations, quality control, pharmacovigilance, and supply of medicines to domestic and international markets. Krasfarma also conducts development of new drug formulations and supports the production of medicines used in the treatment of infectious and other serious medical conditions.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202512/31/2025Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Andrey V.Bryzgalin 42
General Director (CEO) Natalia V.Novikova 53 8/23/2009 11/1/2005
Chief Accountant Marina V.Davydova
6 additional Officers and Directors records available in full report.

Business Names
Business Name
KFAR
Krasfarma OAO

General Information
Number of Employees: 671 (As of 12/31/2025)
Outstanding Shares: 9,281,239 (As of 12/31/2025)
Shareholders: 423
Stock Exchange: RTB
Fax Number: +7 3912611744


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 25, 2026